Evidence map›Paper›PMID 38741962›Full record

ArticleRSC advances2024

Ultrasmall copper nanoclusters as an efficient antibacterial agent for primary peritonitis therapy.

Yaru Wang, Jingrun Ye, Kang Liu, Yinghao Wu, Jiayi Linghu, Ting Feng, Yong Liu, Xinyue Dou, Xun Yuan, Haiguang Zhu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in RSC advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yaru WangSchool of Materials Science and Engineering, Qingdao University of Science and Technology Qingdao 266042 PR China yuanxun@qust.edu.cn zhuhg@qust.edu.cn.
Jingrun YeSchool of Chemistry and Molecular Engineering, Qingdao University of Science and Technology Qingdao 266042 PR China.
Kang LiuSchool of Materials Science and Engineering, Qingdao University of Science and Technology Qingdao 266042 PR China yuanxun@qust.edu.cn zhuhg@qust.edu.cn.
Yinghao WuSchool of Materials Science and Engineering, Qingdao University of Science and Technology Qingdao 266042 PR China yuanxun@qust.edu.cn zhuhg@qust.edu.cn.
Jiayi LinghuSchool of Materials Science and Engineering, Qingdao University of Science and Technology Qingdao 266042 PR China yuanxun@qust.edu.cn zhuhg@qust.edu.cn.
Ting FengSchool of Materials Science and Engineering, Qingdao University of Science and Technology Qingdao 266042 PR China yuanxun@qust.edu.cn zhuhg@qust.edu.cn.
Yong LiuSchool of Materials Science and Engineering, Qingdao University of Science and Technology Qingdao 266042 PR China yuanxun@qust.edu.cn zhuhg@qust.edu.cn.ORCID https://orcid.org/0000-0003-3045-0179
Xinyue DouSchool of Materials Science and Engineering, Qingdao University of Science and Technology Qingdao 266042 PR China yuanxun@qust.edu.cn zhuhg@qust.edu.cn.
Xun YuanSchool of Materials Science and Engineering, Qingdao University of Science and Technology Qingdao 266042 PR China yuanxun@qust.edu.cn zhuhg@qust.edu.cn.ORCID https://orcid.org/0000-0002-6539-3242
Haiguang ZhuSchool of Materials Science and Engineering, Qingdao University of Science and Technology Qingdao 266042 PR China yuanxun@qust.edu.cn zhuhg@qust.edu.cn.ORCID https://orcid.org/0000-0001-5446-9785

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The urgent need to develop biocompatible, non-resistant antibacterial agents to effectively combat Gram-negative bacterial infections, particularly for the treatment of peritonitis, presents a significant challenge. In this study, we introduce our water-soluble Cu

Identifiers

PMID38741962
PMCPMC11089525

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.